More
    Guided Solutions - Connecting Talent With Innovation/div>

    Sonorous Neurovascular earns FDA breakthrough mark for novel stent

    Sonorous Neurovascular received FDA breakthrough device designation for its BosSTENT device intended to treat pulsatile tinnitus, the company announced. “The BosSTENT represents years of focused innovation to deliver an on-label, minimally invasive solution that normalizes...

    Sonorous Neurovascular earns FDA breakthrough mark for novel stent

    Sonorous Neurovascular received FDA breakthrough device designation for its BosSTENT device intended to treat pulsatile tinnitus, the company announced. “The BosSTENT represents years of focused...

    Median Technologies receives FDA 510(k) clearance for eyonis LCS, an AI-based detection and diagnosis device for lung cancer screening

    Median Technologies, developer of eyonis, a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for early cancer diagnosis, and a...

    NuVision Biotherapies raises £4.8m to boost overseas expansion

    NuVision Biotherapies, a spin-out whose products speed up healing of eye conditions, has raised a further £4.8m in a funding round led by the...

    GS MedTech Funding Tracker – Medtronic, Reinsberg Group, and more

    The massive $330 million fund from Santé Ventures signals a major shift toward high-complexity MedTech and digital health. With industry deal value reaching a...
    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    Finance

    Funding

    Clinical Trials

    Artivion’s aortic stents boost post-surgical outcomes in interventional studies

    Artivion has debuted long-term clinical data on two of its cardiac stent products, revealing each’s solution’s potential to offer extended benefits to patients. This includes...

    Biotronik completes first human implants of LivIQ leadless pacemaker

    Biotronik announced the successful first-in-human implantations of its LivIQ leadless pacemaker system. The implants came in Australia as part of the company’s BIO|CONCEPT.LivIQ study, a...

    Robocath launches first-in-human study of next-gen robot for coronary artery disease

    Robocath announced that it launched a first-in-human clinical study evaluating its new robotic system in coronary artery disease. The Rouen, France-based company said its second-generation...

    ReGelTec shows Percutaneous Hydrogel Implant improves chronic low back pain

    ReGelTec Inc., a company developing a percutaneous hydrogel implant for the treatment of chronic low back pain caused by degenerative disc disease, announced the...

    Innovation

    Regulatory Approvals

    Sonorous Neurovascular earns FDA breakthrough mark for novel stent

    Sonorous Neurovascular received FDA breakthrough device designation for its BosSTENT device intended to treat pulsatile tinnitus, the company announced. “The BosSTENT represents years of focused...

    Median Technologies receives FDA 510(k) clearance for eyonis LCS, an AI-based detection and diagnosis device for lung cancer screening

    Median Technologies, developer of eyonis, a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for early cancer diagnosis, and a...

    NuVision Biotherapies raises £4.8m to boost overseas expansion

    NuVision Biotherapies, a spin-out whose products speed up healing of eye conditions, has raised a further £4.8m in a funding round led by the...

    GS MedTech Funding Tracker – Medtronic, Reinsberg Group, and more

    The massive $330 million fund from Santé Ventures signals a major shift toward high-complexity MedTech and digital health. With industry deal value reaching a...

    M&A

    Archives

    Latest articles